These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10454969)

  • 21. Antibody-targeted thrombolytic agents.
    Haber E; Quertermous T; Matsueda GR; Runge MS; Bode C
    Jpn Circ J; 1990 Apr; 54(4):345-53. PubMed ID: 2204740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy and the new environment of medical practice.
    DeMaria AN
    J Am Coll Cardiol; 1988 Jul; 12(1):284-5. PubMed ID: 3132497
    [No Abstract]   [Full Text] [Related]  

  • 23. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Streptokinase audit at Thames Hospital.
    May J
    N Z Med J; 1995 Oct; 108(1010):443. PubMed ID: 7478352
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute myocardial infarction following the use of antimigraine therapy.
    Mikhail GW; Airoldi F; Colombo A
    J Invasive Cardiol; 2004 Oct; 16(10):602-3. PubMed ID: 15505362
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombolysis in apoplexy].
    Truelsen T; Handberg J; Meden P; Overgaard K; Andersen G
    Ugeskr Laeger; 2002 Dec; 165(1):55-6; author reply 56. PubMed ID: 12529954
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy for acute myocardial infarction: what dose should be used?
    Conti CR
    Clin Cardiol; 2000 Sep; 23(9):635-6. PubMed ID: 11016011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Streptokinase--yes or no--a black and white view].
    Dvorák K
    Vnitr Lek; 2003 Nov; 49(11):842-4. PubMed ID: 14689679
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypersensitivity reactions to streptokinase.
    Singh J; Hart G
    Eur Heart J; 1994 Aug; 15(8):1153-4. PubMed ID: 7988614
    [No Abstract]   [Full Text] [Related]  

  • 30. [Does streptokinase still have a role in the treatment of acute myocardial infarct?].
    Janousek S
    Vnitr Lek; 2003 Nov; 49(11):880-4. PubMed ID: 14689685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antistreptokinase antibodies following a dose of streptokinase.
    Chesser SL; Mauro VF
    Ann Pharmacother; 1994 Feb; 28(2):204-6. PubMed ID: 8173136
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombolytic therapy and percutaneous coronary intervention in unstable angina.
    Ambrose JA; Coppola JT
    Semin Interv Cardiol; 2000 Sep; 5(3):129-35. PubMed ID: 11054910
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
    Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
    Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
    Teslia AN; Kolesnikov SA; Mikhaĭlov AA
    Voen Med Zh; 1999 Jul; 320(7):40-4. PubMed ID: 10484919
    [No Abstract]   [Full Text] [Related]  

  • 35. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction?
    Dragu R; Behar S; Sandach A; Boyko V; Kapeliovich M; Rispler S; Hammerman H
    Am J Cardiol; 2006 Apr; 97(8):1142-5. PubMed ID: 16616015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptokinase for inferior myocardial infarction.
    Bates E
    Ann Intern Med; 1991 Apr; 114(8):701-2. PubMed ID: 2003720
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicenter clinical trial using an accelerated streptokinase regimen in patients with acute myocardial infarction.
    Xu C; Zhang T
    Chin Med J (Engl); 2000 Aug; 113(8):733-6. PubMed ID: 11776059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
    Barbagelata A; Califf RM; Sgarbossa EB; Knight D; Mark DB; Granger CB; Armstrong PW; Elizari M; Birnbaum Y; Grinfeld LR; Ohman EM; Wagner GS;
    Am Heart J; 2004 Nov; 148(5):795-802. PubMed ID: 15523309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.